These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1991 related articles for article (PubMed ID: 8406981)

  • 1. Cutaneous malignant melanoma: association with height, weight and body-surface area. a prospective study in Norway.
    Thune I; Olsen A; Albrektsen G; Tretli S
    Int J Cancer; 1993 Oct; 55(4):555-61. PubMed ID: 8406981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy.
    Gallus S; Naldi L; Martin L; Martinelli M; La Vecchia C;
    Melanoma Res; 2006 Feb; 16(1):83-7. PubMed ID: 16432461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort.
    Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Rees JR; Robsahm TE
    Int J Cancer; 2018 Feb; 142(4):681-690. PubMed ID: 28983909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort.
    Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Støer NC; Rees JR; Robsahm TE
    Br J Dermatol; 2018 Sep; 179(3):632-641. PubMed ID: 29858512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women.
    Veierød MB; Thelle DS; Laake P
    Int J Cancer; 1997 May; 71(4):600-4. PubMed ID: 9178814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of measured body size and height and risk of keratinocyte cancers and melanoma.
    Lahmann PH; Hughes MC; Williams GM; Green AC
    Cancer Epidemiol; 2016 Feb; 40():119-25. PubMed ID: 26707237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.
    Chen YT; Zheng T; Holford TR; Berwick M; Dubrow R
    Cancer Causes Control; 1994 Jul; 5(4):341-50. PubMed ID: 8080946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric factors and risk of melanoma in women: a pooled analysis.
    Olsen CM; Green AC; Zens MS; Stukel TA; Bataille V; Berwick M; Elwood JM; Gallagher R; Holly EA; Kirkpatrick C; Mack T; Østerlind A; Rosso S; Swerdlow AJ; Karagas MR
    Int J Cancer; 2008 Mar; 122(5):1100-8. PubMed ID: 17990316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood Body Size and the Risk of Malignant Melanoma in Adulthood.
    Meyle KD; Gamborg M; Sørensen TIA; Baker JL
    Am J Epidemiol; 2017 Apr; 185(8):673-680. PubMed ID: 28369155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of having a home garden on personal UVR exposure behavior and risk of cutaneous malignant melanoma in Denmark.
    Idorn LW; Thieden E; Philipsen PA; Wulf HC
    Int J Cancer; 2013 Mar; 132(6):1383-8. PubMed ID: 22821769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
    Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
    J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous malignant melanoma in Norway: variation by region of residence before and after the age 17.
    Robsahm TE; Tretli S
    Cancer Causes Control; 2001 Aug; 12(6):569-76. PubMed ID: 11519765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometric features and cutaneous melanoma risk: a prospective cohort study in French women.
    Kvaskoff M; Bijon A; Mesrine S; Vilier A; Clavel-Chapelon F; Boutron-Ruault MC
    Cancer Epidemiol; 2014 Aug; 38(4):357-63. PubMed ID: 24986641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do perinatal and early life exposures influence the risk of malignant melanoma? A Northern Ireland birth cohort analysis.
    O'Rorke MA; Black C; Murray LJ; Cardwell CR; Gavin AT; Cantwell MM
    Eur J Cancer; 2013 Mar; 49(5):1109-16. PubMed ID: 23146960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Season of birth and other perinatal risk factors for melanoma.
    Crump C; Sundquist K; Sieh W; Winkleby MA; Sundquist J
    Int J Epidemiol; 2014 Jun; 43(3):793-801. PubMed ID: 24453238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do larger people have more naevi? Naevus frequency versus naevus density.
    Walter SD; Ashbolt R; Dwyer T; Marrett LD
    Int J Epidemiol; 2000 Dec; 29(6):1025-30. PubMed ID: 11101543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
    Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
    Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
    Randi G; Naldi L; Gallus S; Di Landro A; La Vecchia C;
    J Invest Dermatol; 2006 Sep; 126(9):2106-10. PubMed ID: 16645584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body site of cutaneous malignant melanoma--a study on patients with hereditary and multiple sporadic tumours.
    Gillgren P; Brattström G; Frisell J; Palmgren J; Ringborg U; Hansson J
    Melanoma Res; 2003 Jun; 13(3):279-86. PubMed ID: 12777983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cutaneous malignant melanoma in Israel, 1960-1989.
    Iscovich J; Andreev H; Steinitz R
    Public Health Rev; 1995; 23(1):1-23. PubMed ID: 7761605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.